Clifford Hudis, MD, FACP, FASCO, is the CEO of the American Society of Clinical Oncology (ASCO) and serves as Executive Vice Chair of its foundation (Conquer Cancer). He oversees a staff of more nearly 500 who serve a global membership of more than 50,000 members in 170 countries as they seek to reduce the burden of cancer through research, education, and promotion of the highest quality, equitable patient care. ASCO holds the largest annual global meeting focused on cancer research and care, publishes the high impact Journal of Clinical Oncology, defines optimal quality of care, and advocates for access to it. ASCO’s foundation, Conquer Cancer is the largest philanthropic funder of early career cancer researchers through its Young Investigator Award (YIA) and other programs.
Prior to assuming his roles at ASCO in 2016, Dr. Hudis was the Chief of the Breast Cancer Medicine Service, Solid Tumor Division, and an Attending Physician at the Memorial Hospital for Cancer and Allied Diseases and a Professor of Medicine at the Joan & Sanford Weill Medical College of Cornell University Medical College both in New York City. Over nearly three decades, his team identified novel risk factors for cancer linked to inflammation and obesity and developed new drugs (G-CSF, taxanes, anti-HER2 agents) and regimens that raised the global standard of care across all stages of breast cancer.
In 1983 Dr. Hudis received his medical degree from The Medical College of Pennsylvania in Philadelphia, Pennsylvania through a 6-year combined BA-MD program with Lehigh University. He completed his internship and residency in Internal Medicine at The Hospital of the Medical College of Pennsylvania where he then served as Chief Medical Resident. He completed a fellowship in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York in 1991 and then joined the faculty where he continues to volunteer as a clinical consultant.
Dr. Hudis is a Trustee of Drexel University and of the East Hampton Health Care Foundation.